Literature DB >> 22459259

A comparative descriptive study examining the perceptions of cancer patients, family caregivers, and nurses on patient symptom severity in Turkey.

Semiha Akin1, Zehra Durna.   

Abstract

PURPOSE: Perform a comparative descriptive study that aims to describe the symptom severity of patients receiving chemotherapy and to compare patient self-reports of symptom severity with inferences made by nurses and family caregivers. METHODS AND SAMPLE: The study was performed in the chemotherapy unit of a university hospital. The study was conducted on 119 patients undergoing chemotherapy that had a family caregiver and a nurse (n = 7) primarily responsible for their care. Symptom assessments were completed using the Edmonton Symptom Assessment System (ESAS). Symptoms were rated independently by the patient, caregiver and nurse.
RESULTS: The patients reported severe tiredness, loss of well-being, anxiety, drowsiness, appetite changes, depression, pain and nausea. The patients and caregivers showed a strong agreement of the patients' symptoms (P < .001). Patients and nurses showed poor to fair agreement of the symptoms of pain, tiredness, nausea, depression, drowsiness, appetite, loss of well-being, skin and nail changes, mouth sores, and hand numbness (P < .05). The patients' mean scores of symptoms such as pain, depression, anxiety, drowsiness and loss of well-being were lower than those of the caregivers. The patients' mean scores of symptoms such as tiredness, shortness of breath, skin and nail changes and mouth sores were higher than scores of nurses (P < .05).
CONCLUSION: Perceptions of formal or informal caregivers about symptoms in patients with cancer will help clinicians to develop strategies or approaches to improve the caregiver symptom assessment.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22459259     DOI: 10.1016/j.ejon.2012.02.002

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  8 in total

1.  Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians.

Authors:  Karin Oechsle; Kathrin Goerth; Carsten Bokemeyer; Anja Mehnert
Journal:  Support Care Cancer       Date:  2013-02-21       Impact factor: 3.603

2.  Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy.

Authors:  Sun Young Rha; Mira Park; Jiyeon Lee
Journal:  Support Care Cancer       Date:  2018-08-17       Impact factor: 3.603

3.  Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life.

Authors:  Sun Young Rha; Jiyeon Lee
Journal:  Support Care Cancer       Date:  2016-12-28       Impact factor: 3.603

4.  Pain in cancer patients: pain assessment by patients and family caregivers and problems experienced by caregivers.

Authors:  Özlem Ovayolu; Nimet Ovayolu; Sema Aytaç; Sibel Serçe; Alper Sevinc
Journal:  Support Care Cancer       Date:  2014-12-05       Impact factor: 3.603

5.  Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain.

Authors:  Jack Fu; An Ngo; Ki Shin; Eduardo Bruera
Journal:  J Palliat Med       Date:  2013-11-16       Impact factor: 2.947

6.  A modified Edmonton Symptom Assessment Scale for symptom clusters in radiation oncology patients.

Authors:  Peter A S Johnstone; Jae Lee; Jun-Min Zhou; Zhenjun Ma; Diane Portman; Heather Jim; Hsiang-Hsuan Michael Yu
Journal:  Cancer Med       Date:  2017-08-04       Impact factor: 4.452

7.  Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.

Authors:  Divine E Ediebah; Jaap C Reijneveld; Martin J B Taphoorn; Corneel Coens; Efstathios Zikos; Neil K Aaronson; Jan J Heimans; Andrew Bottomley; Martin Klein
Journal:  Qual Life Res       Date:  2016-10-15       Impact factor: 4.147

8.  Patient-Proxy Agreement Regarding Health-Related Quality of Life in Survivors with Lymphoma: A Propensity-Score Matching Analysis.

Authors:  Richard Huan Xu; Dong Dong
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.